ClinicalTrials.govpublic full text
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
prostate adenocarcinoma, prostate neoplasm, prostate cancer, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837353
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.